Adiponectin protects against cardiac fibrosis but not the formation of atherosclerotic lesions in LDL receptor deficient mice

被引：0
|
作者：
Nawrocki, A. R. [1 ]
Hofmann, S. M. [2 ]
Teupser, D. [3 ]
Basford, J. E. [2 ]
Rickes, E. L. [1 ]
Tanowitz, H. B. [4 ]
Chang, C. H. [1 ]
Hui, D. Y. [2 ]
Scherer, P. E. [5 ]
机构：
[1] Merck Res Labs, Rahway, NJ USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[3] Univ Hosp Leipzig, Leipzig, Germany
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2008年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [41] LIGUZINEDIOL PROTECTS AGAINST CARDIAC FIBROSIS IN CARDIAC FIBROBLASTS
    Li, Y.
    Zhu, Q.
    Yin, Q.
    Song, P.
    Bian, H.
    Li, W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 35 - 35
  • [42] Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
    Wang, Fei
    He, Yajuan
    Yao, Naijuan
    Ruan, Litao
    Tian, Zhen
    CARDIOVASCULAR THERAPEUTICS, 2022, 2022
  • [43] Vaccination against CD99 inhibits atherogenesis is Ldl receptor deficient mice
    van Wanrooij, EJ
    de Vos, P
    Bixel, G
    Vestweber, D
    van Berkel, T
    Kuiper, J
    CIRCULATION, 2005, 112 (17) : U319 - U319
  • [44] INCREASED AUTOANTIBODY TITERS AGAINST EPITOPES OF OXIDIZED LDL IN LDL RECEPTOR-DEFICIENT MICE WITH INCREASED ATHEROSCLEROSIS
    PALINSKI, W
    TANGIRALA, RK
    MILLER, E
    YOUNG, SG
    WITZTUM, JL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (10) : 1569 - 1576
  • [45] Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-α
    Fujita, Koichi
    Maeda, Norikazu
    Sonoda, Mina
    Ohashi, Koji
    Hibuse, Toshiyuki
    Nishizawa, Hitoshi
    Nishida, Makoto
    Hiuge, Aki
    Kurata, Akifumi
    Kihara, Shinji
    Shimomura, Iichiro
    Funahashi, Tohru
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) : 863 - 870
  • [46] DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice
    Petrovan, Ramona J.
    Kaplan, Charles D.
    Reisfeld, Ralph A.
    Curtiss, Linda K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (05) : 1095 - 1100
  • [47] HDL-associated platelet-activating factor acetylhydrolase (PAF-AH) reduces atherosclerotic lesions in LDL receptor-deficient mice
    Bruins, M
    Von der Thüsen, J
    Fekkes, M
    Holvoet, P
    Quarck, R
    Van Berkel, T
    Biessen, EAI
    CIRCULATION, 2001, 104 (17) : 329 - 329
  • [48] Stage-Specific Remodeling of Atherosclerotic Lesions upon Cholesterol Lowering in LDL Receptor Knockout Mice
    Zhao, Ying
    Ye, Dan
    Wang, Jun
    Calpe-Berdiel, Laura
    Azzis, Saaleha B. R. N.
    Van Berkel, Theo J. C.
    Van Eck, Miranda
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (03): : 1522 - 1532
  • [49] Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice
    Webb, NR
    Bostrom, MA
    Szilvassy, SJ
    van der Westhuyzen, DR
    Daugherty, A
    de Beer, FC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) : 263 - 268
  • [50] Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL receptor knockout mice
    Ishikawa, K
    Wang, XP
    Qiao, JH
    Navab, M
    Fogelman, AM
    Lusis, AJ
    CIRCULATION, 1997, 96 (08) : 619 - 619
12345